December 27, 2011
J.K. Wall
Dr. Bryan Schneider, a professor at the Indiana University School of Medicine, led a team of researchers
in identifying genetic variations that dispose some breast cancer patients to neuropathy when they are receiving chemotherapy
with the drug Taxol. Schneider’s research was named one of the biggest advances in cancer research this year by the
American Society of Clinical Oncology. The society’s foundation also gave Schneider a three-year, $450,000 grant to
further the research.
More
December 12, 2011
J.K. WallIn 1993, only 3.8 percent of Hoosier adults had full-blown diabetes, compared with 9.8 percent today.
More
December 7, 2011
Bloomberg NewsEli Lilly and Co. stock rose to a one-month high Tuesday after an analyst said the possible success of the company’s
experimental Alzheimer’s drug could double the share price.
More
December 5, 2011
J.K. WallCarmel resident David Wasilewski has launched WhatNext, a website that uses algorithms to make it easier
for cancer patients to connect with others in similar circumstances. Wasilewski, 39, spent eight years as chief operating
officer of the Spanx line of body shapers and did health care consulting before that. In addition to helping patients, he
thinks WhatNext can become a way for health care organizations share their expertise with patients in need.
More
November 8, 2011
Bloomberg News, Associated PressAmylin Pharmaceuticals Inc. and Eli Lilly and Co. have agreed to end a decade-long diabetes partnership to resolve litigation.
Amylin will make an upfront payment of $250 million to Lilly and future revenue-sharing payments of $1.2 billion plus interest.
More
November 7, 2011
J.K. WallRoche Diagnostics will partner with a San Diego firm to incorporate its continuous glucose monitoring sensor with a wireless
handheld device Roche is developing to help diabetics test their blood sugar and track their glucose levels throughout the
day.
More
November 2, 2011
Bloomberg NewsEli Lilly and Co. hid the diabetes risks of Zyprexa to protect sales, a lawyer for the family of a 20-year-old patient who
died while taking the medicine told a jury in the first case to go to trial over the drug. The attorney asked jurors to award
the family $40 million in compensatory damages.
More
November 1, 2011
J.K. WallThe grant is the fifth consecutive five-year grant the Alzheimer Disease Center has received from NIH to support research
to understand the causes and potential treatments for Alzheimer’s and other forms of dementia.
More
October 29, 2011
Greg AndrewsAnalysts have eyes on trial data for drug that could be a game-changer for the company.
More
October 7, 2011
Cialis, Lilly's blockbuster erectile dysfunction drug, now can be taken to treat enlarged prostate. FDA approval means men
who suffer from both disorders can take one medication.
More
September 16, 2011
Bloomberg NewsA German researcher disputed the validity of a study that found Byetta and another diabetes drug increase cancer risk.
More
September 15, 2011
Scott OlsonDr. Murray Korc, an internationally known pancreatic cancer researcher, comes to the cancer center as the first Myles Brand
Professor of Cancer Research. The position is funded through a Lilly Endowment grant.
More
June 27, 2011
Bloomberg NewsEli Lilly and Co., Amylin Pharmaceuticals Inc. and Alkermes Inc. said an analysis of a 148-patient trial found no evidence
that their experimental Bydureon diabetes drug causes prolonged heart rhythms.
More
June 24, 2011
Bloomberg NewsEli Lilly and Co. and Boehringer Ingelheim GmbH’s Trajenta medicine for Type 2 diabetes has been recommended for approval
in Europe, putting the drug on track to enter the region’s market this year.
More
May 25, 2011
Scientists with Roche Holding AG, the parent company of Indianapolis-based Roche Diagnostics Corp., may have found a way to
overcome a blood barrier that keeps drugs from directly entering the brain, potentially opening new pathways to attack Alzheimer’s
disease.
More
May 11, 2011
Bloomberg NewsEli Lilly and Co.’s Amyvid, an experimental imaging agent to detect signs of Alzheimer’s disease in the brain,
shouldn’t be approved because of unreliable study results, a consumer-advocacy group said.
More
May 2, 2011
IBJ Staff and Associated PressThe Food and Drug Administration says it has approved a new diabetes pill from Boehringer Ingelheim and Eli Lilly for patients
who can't control their blood sugar with older medicines.
More
April 26, 2011
J.K. WallEli Lilly and Co. plans to use an implantable drug-delivery system made by Medtronic Inc. to precisely target patients'
brains with an experimental drug for Parkinson’s disease.
More
April 25, 2011
J.K. WallRoche Diagnostics Corp. won regulatory approval for a new HPV test, giving it a technological edge in the $300 million market
for automated cervical cancer tests.
More
April 16, 2011
Associated PressEli Lilly and Co. Inc. said Friday that the FDA has asked the drugmaker to conduct another clinical trial of its proposed
pancreas drug before it resubmits an application to have the drug approved for sale.
More
April 9, 2011
J.K. WallThe Indiana University School of Medicine has licensed a pediatric psychiatrist's patent on
an alcohol-dependency drug that the doctor discovered improves the language and social skills of autism patients. IU has licensed
the patent to Indianapolis-based Confluence Pharmaceuticals Inc.
More
March 18, 2011
Bloomberg NewsThe Food and Drug Administration said Lilly needs to create a training program to ensure brain scans are interpreted properly.
More
March 17, 2011
Bloomberg NewsEli Lilly and Co.’s patent-infringement claim over Hospira Inc.’s generic version of the cancer treatment Gemzar will be investigated
by a U.S. trade agency with the power to block imports of the copycat drug.
More
March 3, 2011
Bloomberg NewsBydureon, the diabetes drug being developed by Amylin Pharmaceuticals Inc., Eli Lilly and Co. and Alkermes Inc., didn’t
control the disease better than Novo Nordisk A/S’s Victoza in a study.
More
February 12, 2011
Greg AndrewsNew investors got in for $6 a share—which is less than the average price paid by prior investors, a regulatory filing
reveals.
More
Poor little LadyJ! Typical Democommie. In case it got past you, the dems have totally screwed this country in the past 3+ years. We have a democommie in the White House who apparently never read the Constitution, while claiming to be a constitutional scholar. We had a democommie-controlled Congress (opposite of PROGRESS?)passing bills that "we'll have to pass before we know what's in it". This impostor president has violated the U. S. Constitution too many times to count. The Attorney General is a race-baiting gunrunner that refuses to stop illegal immigration. And, the head of NASA, a once-proud agency that put several men on the moon, is now our liason to the murderous Muslims. Great job, democommies! Sometimes I wish they really would try to take our guns.
Pat Bauer try t do right about the state but the Republican leader and all of them did not think of us. Only the money they will get from their rich corporation. Of Course the Democrats had union, so I won't vote for Bosma or whatever his name is.
Well you are talking about Republican, did all of the Damage in this state. Sure the Democrats did some but most is the Republican. The Republican set us back not going forward. Hurry passed bills won't listen to any amendment our way only. The Republicans drew up these district so they could win again. Which is a crying shame. I will not vote for any Republican and I got the list who voted for the RTW Bill and who didn't. Tired of the Republicans
Actually, it was Greenspan who encouraged the elderly to refinance their homes, using their equity to boost the economy after 9/11. In addition, it was George Bush and Barney Frank who jointly suggested that everyone should hold a piece of the rock. It was the Bush Administration, namely Treasury Secretary Paulson who deregulated Wall Street and Lenders such as Countrywide, Washington Mutual, Wachovia, Bank of America, and Wells Fargo. When the TARP Bailout Proposal went to Capitol Hill in October 2008, Treasury Secretary Paulson asked for, and received, full immunity from future prosecution, dating back to his time as CEO of Goldman Sachs, the co-recipient of the initial $350 Billion Dollar Tarp Bailout Payment for Wall Street, back in October 2008. It was the US Treasury and the Federal Reserve, both controlled by the Bush Administration, that created sub-prime mortgages, starting in 2004. Many members of the House and Senate, on both sides of the aisle, benefited from home mortgage refinancing. Banks, appraisers, and realtors pushed people into home mortgages they had no business accepting, based on claims that the housing market would only get better. Average Americans did not create Credit Default Swaps, I think those creations happened on Wall Street. Spend some time at the library, you will be shocked by what your research brings forth.
They need to pay their fines and the judge blocking the fines needs to be investigated. I'm sick and tired of democrats and their spending. We went broke with every dem as gov. too. Pat Bauer needs to go!